Alpha 2 agonist dexmedetomidine may reduce duration of delirium in critically ill adults.
| Autor: | Hill J; Health Technology Assessment Group, University of Central Lancashire, Preston, Lancashire, UK jehill1@uclan.ac.uk., Sange C; Diabetes Research Nurse/FCA Coach, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, UK., Clegg A; Health Technology Assessment Group, University of Central Lancashire, Preston, Lancashire, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Evidence-based nursing [Evid Based Nurs] 2020 Jun 17. Date of Electronic Publication: 2020 Jun 17. |
| DOI: | 10.1136/ebnurs-2019-103215 |
| Abstrakt: | Competing Interests: Competing interests: None declared. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|